Cargando…

Prevalencia de diarrea en pacientes adultos en terapia intensiva y su relación con las fórmulas enterales listas para utilizar

INTRODUCTION: Diarrhea is a frequent complication in critically ill patients. Its origin is multifactorial. The objective of this work is to analyze the relationship between 5 ready-to-use formulas and the development of diarrhea in critically ill patients. METHODS: Retrospective study where the vol...

Descripción completa

Detalles Bibliográficos
Autores principales: Chapela, Sebastián Pablo, Martinez, Pablo Ignacio, Reberendo, María Jimena, Llobera, Natalia Daniela, Ernst, Glenda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Universidad Nacional de Córdoba 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9590831/
https://www.ncbi.nlm.nih.gov/pubmed/36149067
http://dx.doi.org/10.31053/1853.0605.v79.n3.36975
_version_ 1784814576450142208
author Chapela, Sebastián Pablo
Martinez, Pablo Ignacio
Reberendo, María Jimena
Llobera, Natalia Daniela
Ernst, Glenda
author_facet Chapela, Sebastián Pablo
Martinez, Pablo Ignacio
Reberendo, María Jimena
Llobera, Natalia Daniela
Ernst, Glenda
author_sort Chapela, Sebastián Pablo
collection PubMed
description INTRODUCTION: Diarrhea is a frequent complication in critically ill patients. Its origin is multifactorial. The objective of this work is to analyze the relationship between 5 ready-to-use formulas and the development of diarrhea in critically ill patients. METHODS: Retrospective study where the volume of the stools of 315 patients and the presence of diarrhea defined with a cut-off point of a volume of 250 ml/day were evaluated. 35.34% of the patients presented diarrhea with said cut-off point. The mean volume of stools was 269.20 ml (95% CI: 255.05-283.06). RESULTS: It was observed that all the formulas analyzed had a slight correlation with the Spearman test between the volume provided and the volume of stools, being: Nutricia Nutrison ® (R: 0.159; P: 0.053), Nutricia Multifibra ® (R: 0.296; <0.001), Nutricia Peptisorb ® (R: 0.323; P<0.001), Nutricia Protison ® (R: 0.108; P<0.001), Fresenius Supportan ® (R: 0.152; P<0.001). Multivariate analysis was performed and it was observed that there were no differences in the incidence of diarrhea between the different enteral formulas during the first 10 days. The change of formulas during hospitalization would be a predisposing factor for diarrhea. CONCLUSION: Therefore, the formula and the volume provided are factors that could influence whether patients have diarrhoea. Understanding these possible influences in a deeper way will allow the safest choice of enteral formulas for a patient with diarrhea.
format Online
Article
Text
id pubmed-9590831
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Universidad Nacional de Córdoba
record_format MEDLINE/PubMed
spelling pubmed-95908312022-10-26 Prevalencia de diarrea en pacientes adultos en terapia intensiva y su relación con las fórmulas enterales listas para utilizar Chapela, Sebastián Pablo Martinez, Pablo Ignacio Reberendo, María Jimena Llobera, Natalia Daniela Ernst, Glenda Rev Fac Cien Med Univ Nac Cordoba Artículos Originales INTRODUCTION: Diarrhea is a frequent complication in critically ill patients. Its origin is multifactorial. The objective of this work is to analyze the relationship between 5 ready-to-use formulas and the development of diarrhea in critically ill patients. METHODS: Retrospective study where the volume of the stools of 315 patients and the presence of diarrhea defined with a cut-off point of a volume of 250 ml/day were evaluated. 35.34% of the patients presented diarrhea with said cut-off point. The mean volume of stools was 269.20 ml (95% CI: 255.05-283.06). RESULTS: It was observed that all the formulas analyzed had a slight correlation with the Spearman test between the volume provided and the volume of stools, being: Nutricia Nutrison ® (R: 0.159; P: 0.053), Nutricia Multifibra ® (R: 0.296; <0.001), Nutricia Peptisorb ® (R: 0.323; P<0.001), Nutricia Protison ® (R: 0.108; P<0.001), Fresenius Supportan ® (R: 0.152; P<0.001). Multivariate analysis was performed and it was observed that there were no differences in the incidence of diarrhea between the different enteral formulas during the first 10 days. The change of formulas during hospitalization would be a predisposing factor for diarrhea. CONCLUSION: Therefore, the formula and the volume provided are factors that could influence whether patients have diarrhoea. Understanding these possible influences in a deeper way will allow the safest choice of enteral formulas for a patient with diarrhea. Universidad Nacional de Córdoba 2022-09-16 /pmc/articles/PMC9590831/ /pubmed/36149067 http://dx.doi.org/10.31053/1853.0605.v79.n3.36975 Text en https://creativecommons.org/licenses/by-nc/4.0/Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.
spellingShingle Artículos Originales
Chapela, Sebastián Pablo
Martinez, Pablo Ignacio
Reberendo, María Jimena
Llobera, Natalia Daniela
Ernst, Glenda
Prevalencia de diarrea en pacientes adultos en terapia intensiva y su relación con las fórmulas enterales listas para utilizar
title Prevalencia de diarrea en pacientes adultos en terapia intensiva y su relación con las fórmulas enterales listas para utilizar
title_full Prevalencia de diarrea en pacientes adultos en terapia intensiva y su relación con las fórmulas enterales listas para utilizar
title_fullStr Prevalencia de diarrea en pacientes adultos en terapia intensiva y su relación con las fórmulas enterales listas para utilizar
title_full_unstemmed Prevalencia de diarrea en pacientes adultos en terapia intensiva y su relación con las fórmulas enterales listas para utilizar
title_short Prevalencia de diarrea en pacientes adultos en terapia intensiva y su relación con las fórmulas enterales listas para utilizar
title_sort prevalencia de diarrea en pacientes adultos en terapia intensiva y su relación con las fórmulas enterales listas para utilizar
topic Artículos Originales
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9590831/
https://www.ncbi.nlm.nih.gov/pubmed/36149067
http://dx.doi.org/10.31053/1853.0605.v79.n3.36975
work_keys_str_mv AT chapelasebastianpablo prevalenciadediarreaenpacientesadultosenterapiaintensivaysurelacionconlasformulasenteraleslistasparautilizar
AT martinezpabloignacio prevalenciadediarreaenpacientesadultosenterapiaintensivaysurelacionconlasformulasenteraleslistasparautilizar
AT reberendomariajimena prevalenciadediarreaenpacientesadultosenterapiaintensivaysurelacionconlasformulasenteraleslistasparautilizar
AT lloberanataliadaniela prevalenciadediarreaenpacientesadultosenterapiaintensivaysurelacionconlasformulasenteraleslistasparautilizar
AT ernstglenda prevalenciadediarreaenpacientesadultosenterapiaintensivaysurelacionconlasformulasenteraleslistasparautilizar